ID   OPM-3
AC   CVCL_M529
DR   Wikidata; Q54936485
RX   PubMed=9858236;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler, Hans Gunther
RA   Matsuo, Yoshinobu
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//
RX   PubMed=9858236; DOI=10.1046/j.1365-2141.1998.01049.x;
RA   Yoshida, Hitoshi
RA   Nishiura, Tetsuo
RA   Karasuno, Takahiro
RA   Matsumura, Itaru
RA   Ishikawa, Jun
RA   Yoshimura, Masafumi
RA   Yokota, Takafumi
RA   Okajima, Yu
RA   Ogawa, Megumu
RA   Kanakura, Yuzuru
RA   Tomiyama, Yoshiaki
RA   Matsuzawa, Yuji
RT   "Effect of the interaction between fibronectin and VLA-4 on the
RT   proliferation of human B cells, especially a novel human B-cell line,
RT   OPM-3.";
RL   Br. J. Haematol. 103:804-812(1998).
//